Target Price | €63.24 |
Price | €46.43 |
Potential | 36.21% |
Number of Estimates | 23 |
23 Analysts have issued a price target Siemens Healthineers 2026 . The average Siemens Healthineers target price is €63.24. This is 36.21% higher than the current stock price. The highest price target is €78.75 69.61% , the lowest is €50.50 8.77% . | |
A rating was issued by 27 analysts: 23 Analysts recommend Siemens Healthineers to buy, 3 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Siemens Healthineers stock has an average upside potential 2026 of 36.21% . Most analysts recommend the Siemens Healthineers stock at Purchase. |
24 Analysts have issued a sales forecast Siemens Healthineers 2025 . The average Siemens Healthineers sales estimate is €23.8b . This is 2.79% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €25.0b 8.17% , the lowest is €22.8b 1.69% .
This results in the following potential growth metrics:
2024 | €22.4b | 3.15% |
---|---|---|
2025 | €23.8b | 6.37% |
2026 | €25.0b | 5.24% |
2027 | €26.6b | 6.19% |
2028 | €28.3b | 6.60% |
2029 | €29.8b | 5.18% |
2030 | €31.3b | 5.05% |
21 Analysts have issued an Siemens Healthineers EBITDA forecast 2025. The average Siemens Healthineers EBITDA estimate is €4.9b . This is 11.70% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €5.5b 26.02% , the lowest is €4.4b 0.71% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €4.0b | 9.30% |
---|---|---|
2025 | €4.9b | 21.48% |
2026 | €5.4b | 10.13% |
2027 | €5.9b | 9.64% |
2028 | €6.4b | 7.37% |
2029 | €6.8b | 6.38% |
2030 | €7.0b | 3.03% |
2024 | 18.03% | 5.96% |
---|---|---|
2025 | 20.59% | 14.20% |
2026 | 21.55% | 4.66% |
2027 | 22.25% | 3.25% |
2028 | 22.41% | 0.72% |
2029 | 22.66% | 1.12% |
2030 | 22.23% | 1.90% |
23 Siemens Healthineers Analysts have issued a net profit forecast 2025. The average Siemens Healthineers net profit estimate is €2.8b . This is 34.34% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €3.3b 60.10% , the lowest is €2.6b 23.65% .
This results in the following potential growth metrics and future Net Margins:
2024 | €1.9b | 28.69% |
---|---|---|
2025 | €2.8b | 44.51% |
2026 | €3.2b | 14.02% |
2027 | €3.6b | 12.14% |
2028 | €3.7b | 3.87% |
2029 | €4.1b | 9.13% |
2024 | 8.68% | 24.76% |
---|---|---|
2025 | 11.80% | 35.88% |
2026 | 12.78% | 8.31% |
2027 | 13.50% | 5.63% |
2028 | 13.15% | 2.59% |
2029 | 13.65% | 3.80% |
23 Analysts have issued a Siemens Healthineers forecast for earnings per share. The average Siemens Healthineers EPS is €2.50 . This is 34.41% higher than earnings per share in the financial year 2024. The highest EPS forecast is €2.98 60.22% , the lowest is €2.30 23.66% .
This results in the following potential growth metrics and future valuations:
2024 | €1.73 | 29.10% |
---|---|---|
2025 | €2.50 | 44.51% |
2026 | €2.85 | 14.00% |
2027 | €3.20 | 12.28% |
2028 | €3.32 | 3.75% |
2029 | €3.63 | 9.34% |
Current | 24.96 | 15.33% |
---|---|---|
2025 | 18.56 | 25.65% |
2026 | 16.27 | 12.34% |
2027 | 14.51 | 10.82% |
2028 | 13.97 | 3.72% |
2029 | 12.80 | 8.38% |
Based on analysts' sales estimates for 2025, the Siemens Healthineers stock is valued at an EV/Sales of 2.75 and an P/S ratio of 2.17 .
This results in the following potential growth metrics and future valuations:
Current | 2.83 | 10.44% |
---|---|---|
2025 | 2.75 | 2.67% |
2026 | 2.62 | 4.98% |
2027 | 2.46 | 5.83% |
2028 | 2.31 | 6.19% |
2029 | 2.20 | 4.93% |
2030 | 2.09 | 4.80% |
Current | 2.23 | 10.93% |
---|---|---|
2025 | 2.17 | 2.71% |
2026 | 2.06 | 4.98% |
2027 | 1.94 | 5.83% |
2028 | 1.82 | 6.19% |
2029 | 1.73 | 4.93% |
2030 | 1.65 | 4.80% |
Siemens Healthineers...
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Buy
➜
Buy
|
Unchanged | Jul 06 2025 |
EQUITA SIM |
Buy
➜
Buy
|
Unchanged | Jul 02 2025 |
BERENBERG |
Buy
➜
Buy
|
Unchanged | Jun 30 2025 |
ROTHSCHILD & CO REDBURN |
Buy
➜
Buy
|
Unchanged | Jun 26 2025 |
METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | May 29 2025 |
HSBC |
Hold
➜
Buy
|
Upgrade | May 25 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Buy
➜
Buy
|
Unchanged | May 07 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Jul 06 2025 |
Unchanged
EQUITA SIM:
Buy
➜
Buy
|
Jul 02 2025 |
Unchanged
BERENBERG:
Buy
➜
Buy
|
Jun 30 2025 |
Unchanged
ROTHSCHILD & CO REDBURN:
Buy
➜
Buy
|
Jun 26 2025 |
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
May 29 2025 |
Upgrade
HSBC:
Hold
➜
Buy
|
May 25 2025 |
Unchanged
LANDESBANK BADEN-WUERTTEMBERG:
Buy
➜
Buy
|
May 07 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.